Skip to main content

Table 1 Patient characteristics and genetic types of WHO II-IV gliomas

From: Feasibility of evaluating the histologic and genetic subtypes of WHO grade II-IV gliomas by diffusion-weighted imaging

Characteristics

LGGs

HGGs

Total

P value

WHO II

n = 36 (32.43%)

WHO III

n = 32 (28.83%)

WHO IV

n = 43 (38.74%)

WHO II-IV

n = 111 (100.00%)

LGGs vs

HGGs

Age

42.4 \(\pm 11.6\)

46.5 \(\pm 12.4\)

57.8 \(\pm 15.0\)

44.3 \(\pm 12.1\)

P < 0.0001

Sex

P = 0.035

 Male

24 (66.67%)

19 (59.38%)

15 (34.88%)

58 (52.25%)

 Female

12 (33.33%)

13 (40.62%)

28 (65.12%)

53 (47.75%)

Genetic type

 

 IDH

P < 0.0001

  Mutation

27 (75.00%)

15 (46.88%)

3 (6.98%)

45 (40.54%)

  Wildtype

9 (25.00%)

17 (53.12%)

39 (90.70%)

65 (58.56%)

  NA

0 (0.00%)

0 (0.00%)

1 (2.32%)

1 (0.90%)

 MGMT

P = 0.002

  Methylated

28 (77.78%)

21 (65.63%)

17 (39.53%)

66 (59.46%)

  Unmethylated

6 (16.67%)

10 (31.25%)

26 (60.47%)

42 (37.84%)

  NA

2 (5.55%)

1 (3.12%)

0 (0.00%)

3 (2.70%)

 TERT

P = 0.471

  Mutation

17 (47.22%)

13 (40.62%)

25 (58.14%)

55 (49.55%)

  Wildtype

17 (47.22%)

15 (46.88%)

13 (30.23%)

45 (40.54%)

  NA

2 (5.56%)

4 (12.50%)

5 (11.63%)

11 (9.91%)

  1. Unless otherwise noted, data in the table are presented as n (%) or mean \(\pm\) standard deviation; NA: not available
  2. LGGs low grade gliomas; HGGs high grade gliomas